Charles River Laboratories Trading Update (Friday 23 Oct 2026)
- Current price: USD 339.66
- Daily change: –1.51 % (closing at 08:27 AM Central Europe)
- Shares outstanding: 47.7 million
- Market capitalization: USD 16.5 billion
- 24‑hour trading volume: USD 904.2 million
- Month‑to‑date performance: +22.48 % since the end of the previous month
- 200‑day simple moving average: USD 217.46
- 52‑week range: high USD 351.21 (22 Oct 2026), low USD 146.2 (19 May 2026)
24‑Hour Performance of Peer Stocks
| Stock | Ticker | Change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Ovintiv | OVV | –0.61 % | USD 69.30 | USD 19.5 bn | 19.78 |
| Best Buy | BBY | +6.07 % | USD 99.83 | USD 19.7 bn | 15.63 |
| Southwest Airlines | LUV | +5.39 % | USD 42.03 | USD 19.5 bn | 25.17 |
| Woodward | WWD | –6.24 % | USD 304.85 | USD 19.2 bn | 36.16 |
| Evergy | EVRG | +2.16 % | USD 84.95 | USD 19.2 bn | 21.11 |
Note on Best Buy: Best Buy’s recent gains are partly attributable to the launch of Apple’s iPhone Duo. The high‑priced foldable device has generated significant customer demand, leading to in‑store queues and inventory shortages. Supply‑chain constraints have delayed deliveries of the new model, yet the retailer continues to manage stock for other Apple products. The situation illustrates the impact of flagship launches on retail supply dynamics and broader electronics pricing trends.
Company Profile
Charles River Laboratories International, Inc. is headquartered in Wilmington, United States, and operates within the healthcare sector. The company supplies research tools and support services for drug discovery and development, specializing in animal research models for new drugs, devices, and therapies. Its client base includes pharmaceutical and biotechnology firms, hospitals, and academic institutions worldwide. Charles River Laboratories International is listed on the New York Stock Exchange; its IPO was conducted on 23 June 2000. For further details, visit the company’s website at www.criver.com .
